LifeSci Capital initiated coverage of Kura Oncology (KURA) with an Outperform rating and $30 price target
Don't Miss out on Research Tools:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter